Engineering smart polymeric lipid nanoparticles for breast cancer: The convergence of AI and medical personalization to enhance efficacy and safety
Authors:
- Usamah SayedUSUsamah Sayed
- Diyora AzamovaDADiyora Azamova
- Abdulqader Faris AbdulqaderAAAbdulqader Faris Abdulqader
- Amir Abdul KadhimAKAmir Abdul Kadhim
- K.V. JamunaKJK.V. Jamuna
- Divya SinghalDSDivya Singhal
- Navin Kumar TailorNTNavin Kumar Tailor
- Djamila PolatovaDPDjamila Polatova
- 3 October 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 705
Abstract
No abstract availableThis publication has 239 references indexed in Scilit:
- Toward Predictable Nanomedicine: Current Forecasting Frameworks for Nanoparticle–Biology InteractionsAdvanced Intelligent Discovery, 2026
- Multifunctional Nanocarrier Drug Delivery Systems: From Diverse Design to Precise Biomedical ApplicationsAdvanced Healthcare Materials, 2025
- MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJAMA Oncology, 2024
- Harnessing the Power of Stimuli‐Responsive Nanoparticles as an Effective Therapeutic Drug Delivery SystemAdvanced Materials, 2024
- Feeding Next‐Generation Nanomedicines to Europe: Regulatory and Quality ChallengesAdvanced Healthcare Materials, 2023
- Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological PathwaysAdvanced Science, 2023
- Examination of Low ERBB2 Protein Expression in Breast Cancer TissueJAMA Oncology, 2022
- Adjuvant Capecitabine in Triple-Negative Breast CancerJAMA, 2021
- Artificial Intelligence and Machine Learning Empower Advanced Biomedical Material Design to Toxicity PredictionAdvanced Intelligent Systems, 2020
- Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering NanomedicineAdvanced Healthcare Materials, 2020